Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

From the Expert: Tips for Research Grant Applications & NIH Funding

Richard Quinn  |  June 24, 2016

Kyu Oh_iStockphoto_money500x270Landing a highly sought after R01 grant from one of the National Institutes of Health (NIH)—such as the National Institute of Allergy and Infectious Diseases (NIAID)—is hard enough for a young rheumatologist. But doing it on the first shot?

Say hello to Martin Kriegel, MD, PhD, an immunologist/rheumatologist at Yale University School of Medicine in New Haven, Conn., and last year’s recipient of a $1.29 million, five-year NIH/NIAID grant for a study on the “Human Gut Commensal Cross-Reactivity in Antiphospholipid Syndrome.”1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“As a young investigator, I think it cannot be stressed more how important it is to establish the right collaborations to demonstrate feasibility of all aspects of the proposal,” says Dr. Kriegel. “It is often impossible to be an expert in all areas, which is why well-chosen collaborators are key to success. I wish I could have more specific recommendations for a successful application, but I would argue there’s no entirely right or wrong way to do it, after having followed some general points the NIH has posted on its website.”

Still, Dr. Kriegel has a few tips for those looking to score a major grant. They include:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Apply for pilot grants as soon as possible, because they hone the writing process and force physicians to think early on about specific aims and best approaches;
  • Tailor proposals to specific agencies, announcements or study sections; trying to anticipate what a funding agency is looking for can make all the difference;
  • Generate enough preliminary data for each aim to make the grant proposal more attractive; and
  • Work with senior faculty and colleagues to review the entire proposal or, at least, get feedback on the specific aims page.

“Developing a logical proposal that builds upon aims that are connected, but are at the same time not dependent on each other—that is perhaps one of the biggest hurdles for young investigators,” Dr. Kriegel says. “Even if the hypothesis is novel and the preliminary data promising, if the proposal is written in a way [in which] the reviewers can criticize or cannot even understand fully what you’re trying to work on, that itself could be a reason why a grant doesn’t get funded.”

Lastly, he adds that scientists should never become discouraged by the rejection of a grant. Most grant agencies will provide written critiques by the reviewers. Those critiques can be a roadmap to a successful 2.0 version of a grant.

“With each grant, one can improve the proposal,” Dr. Kriegel says. “The advantage with NIH grants is that one receives detailed comments on all strengths and weaknesses of the application. It’s very important to take those as an opportunity and incorporate any suggestions for improvement into future applications.”


Richard Quinn is a freelance writer in New Jersey.

Reference

  1. National Institutes of Health. Human gut commensal cross-reactivity in antiphospholipid syndrome. 2015.

Page: 1 2 | Multi-Page
Share: 

Filed under:Career DevelopmentProfessional TopicsResearch Rheum Tagged with:FundingGrantsResearchtips

Related Articles

    Studies Find More Evidence the Microbiome Affects Autoimmune Disease

    August 17, 2018

    Bacteria (e.g., Bifidobacterium, Lactobacillus, Enterococcus and Escherichia coli) colonize different parts of digestive system. Kateryna Kon / shutterstock.com Evidence is accumulating that the microbiome may be an important part of the pathogenesis of many autoimmune diseases. Two recently published articles report on how translocation of the gut bacterium Enterococcus gallinarum drives autoimmunity in mice and…

    Mouse Research Suggests the Microbiome Is Related to Lupus

    July 18, 2019

    Research in type I interferon (IFN) driven mouse models of systemic lupus erythematosus (SLE) suggests the microbiome may play a role in the development of autoimmunity. Additionally, changes in diet may induce protective effects in the gut.1 “Microbes in the gut worsen a lupus model related to the interferon pathway,” says Martin A. Kriegel, MD,…

    Aims Review Committee Helps Rheumatology Researchers Craft Grant Proposals

    August 13, 2017

    There you are, working steadily away on your next manuscript. The ideas are flowing. You’ve hit your stride. Nothing can stop you now—nothing, that is, except a colleague who shows up at your desk with a 20-page grant proposal. “Do you mind?” he asks. Across academia the problem is the same—too few hours in the…

    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    Monkey Business Images/shutterstock.com The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences